Madison-based Immuto Scientific awarded $2.5 million national grant
Madison-based Immuto Scientific, a biotechnology company providing drug discovery services, is the recipient of a $2.5 million Small Business Innovation Research (SBIR) Phase II grant from the National Institutes of Health (NIH).
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed